Zhu Xueyi, Wei Ying, Dong Jingcheng
Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Front Pharmacol. 2020 Sep 11;11:532849. doi: 10.3389/fphar.2020.532849. eCollection 2020.
Asthma is a chronic airway inflammatory disorder related to variable expiratory airflow limitation, leading to wheeze, shortness of breath, chest tightness, and cough. Its characteristic features include airway inflammation, airway remodeling and airway hyperresponsiveness. The pathogenesis of asthma remains extremely complicated and the detailed mechanisms are not clarified. Long noncoding RNAs (lncRNAs) have been reported to play a prominent role in asthma and function as modulators of various aspects in pathological progress of asthma. Here, we summarize recent advances of lncRNAs in asthma pathogenesis to guide future researches, clinical treatment and drug development, including their regulatory functions in the T helper (Th) 1/Th2 imbalance, Th17/T regulatory (Treg) imbalance, eosinophils dysfunction, macrophage polarization, airway smooth muscle cells proliferation, and glucocorticoid insensitivity.
哮喘是一种慢性气道炎症性疾病,与可变的呼气气流受限有关,可导致喘息、气短、胸闷和咳嗽。其特征包括气道炎症、气道重塑和气道高反应性。哮喘的发病机制仍然极其复杂,具体机制尚不清楚。据报道,长链非编码RNA(lncRNA)在哮喘中起重要作用,并在哮喘病理进展的各个方面作为调节因子发挥作用。在此,我们总结lncRNA在哮喘发病机制方面的最新进展,以指导未来的研究、临床治疗和药物开发,包括它们在辅助性T细胞(Th)1/Th2失衡、Th17/调节性T细胞(Treg)失衡、嗜酸性粒细胞功能障碍、巨噬细胞极化、气道平滑肌细胞增殖和糖皮质激素不敏感中的调节功能。